SPHK1 and urinary bladder cancer: An elevated level of miR-125b inhibits cell growth and migration and induces cell cycle arrest in the G1 phase, with a further study showing miR-125b targeting SphK1 and inhibiting bladder cancer progression (Zhao et al., 2015).